Funded Tech Companies

OCON Therapeutics

Researching who backed OCON Therapeutics? RH Capital, Features Capital and Astia Angel joined the equity holders in this innovative manufacturing company.

Company Overview

Contact Information

Company Background Information

Overview

OCON Therapeutics innovates, develops, manufactures, and commercializes cutting-edge women's health products based on our patented IUB® (Intra Uterine Ball) proprietary platform. The IUB® made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

6/24/2024

Financing History

Management Team

Title

Name

Email & Social

Chairman

Anula Jayasuriya

        

Chief Executive Officer

Keren Leshem

        

Chief Financial Officer

Amir Avraham

        

Chief Medical Officer

Sergio Haimovich

        

VP - Marketing

Daniela Schardinger

        

VP - Operations

Rachel Safra-Zafrany

        

VP - Operations

Daniel Sclar

        

VP - Regulatory Affairs

Adely Levy

        

VP - Sales

Susanne Mair

        

Company Investors

• RH Capital
• Features Capital
• Astia Angel

Browse more funded tech companies:

OCOchem | OCR Labs

Share this article

About Our VC Deals Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary